Medicare Enrolled
Dr. Michael Bastien, MD
Optician · Westlake Village, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bastien from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bastien?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bastien
Dr. Michael Bastien is an optician specialist in Westlake Village, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bastien performed 7,651 Medicare services across 3,606 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bastien received a total of $8,534 from 40 pharmaceutical and/or device companies across 219 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bastien is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 11% volume in CA
$8,534 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,651
Medicare services
Top 11% in CA for optician
3,606
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~383 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,883 | $6 | $12 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
839 | $37 | $115 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
795 | $46 | $95 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
748 | $30 | $135 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
529 | $71 | $150 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
513 | $66 | $178 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
437 | $90 | $199 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
190 | $42 | $88 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
182 | $104 | $212 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
86 | $126 | $256 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
83 | $145 | $292 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
66 | $1 | $4 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
52 | $35 | $98 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
32 | $149 | $307 |
| Pathology tissue examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis. |
29 | $11 | $77 |
| Skin growth removal and lab exam, 1-5 blocks This procedure involves the removal of a growth from the head, neck, hands, feet, or genitals. The removed tissue is then examined under a microscope in the laboratory. |
25 | $604 | $1,164 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
24 | $104 | $215 |
| Destruction of small cancerous skin growth on face or mouth This procedure involves the removal or destruction of a cancerous skin lesion measuring 0.5 centimeters or less located on the face, ears, eyelids, nose, lips, or mouth. |
22 | $112 | $242 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 22 | $369 | $712 |
| Destruction of skin growth, 15 or more growths | 20 | $102 | $231 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
20 | $59 | $167 |
| Intermediate wound repair, 2.5 cm or less This procedure involves stitching a wound on the scalp, underarms, trunk, arms, or legs that is 2.5 centimeters or smaller. It includes cleaning the wound and closing it with sutures to promote healing. |
16 | $213 | $458 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $89 | $185 |
| Destruction of cancer skin growth on trunk, arms, or legs, 0.5 cm or less This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that is 0.5 centimeters or smaller in size. |
13 | $82 | $172 |
| Eyelid biopsy A procedure to remove a small sample of tissue from the eyelid for laboratory examination. |
11 | $156 | $324 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,534
Total received (2018-2024)
Avg $1,219/year across 7 years
Top 16% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
219
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,206 (96.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$328 (3.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,292
2023
$1,376
2022
$1,625
2021
$2,009
2020
$240
2019
$1,204
2018
$788
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$325
Arcutis Biotherapeutics, Inc.
$265
ABBVIE INC.
$156
Incyte Corporation
$137
LEO Pharma Inc.
$74
SUN PHARMACEUTICAL INDUSTRIES INC.
$54
Amgen Inc.
$48
PFIZER INC.
$42
Novartis Pharmaceuticals Corporation
$37
Janssen Biotech, Inc.
$34
Galderma Laboratories, L.P.
$32
Verrica Pharmaceuticals Inc.
$24
Smith+Nephew, Inc.
$23
Biofrontera Inc.
$21
UCB, Inc.
$21
Top 3 companies account for 57.7% of 2024 payments
All-time payments by company (2018-2024) ›
iCAD, Inc
$1,646
GENZYME CORPORATION
$977
Amgen Inc.
$421
LEO Pharma Inc.
$394
Incyte Corporation
$364
Arcutis Biotherapeutics, Inc.
$345
EPI Health, LLC
$342
Sun Pharmaceutical Industries Inc.
$327
Galderma Laboratories, L.P.
$308
PruGen, Inc. Pharmaceuticals
$290
Ortho Dermatologics, a division of Bausch Health US, LLC
$268
Journey Medical Corporation
$258
ABBVIE INC.
$246
Regeneron Healthcare Solutions, Inc.
$244
AbbVie Inc.
$198
Lilly USA, LLC
$196
PFIZER INC.
$174
Merz North America, Inc.
$173
Genentech USA, Inc.
$170
Janssen Biotech, Inc.
$155
E.R. Squibb & Sons, L.L.C.
$142
Janssen Scientific Affairs, LLC
$125
Allergan, Inc.
$108
Novartis Pharmaceuticals Corporation
$97
Almirall LLC
$93
SUN PHARMACEUTICAL INDUSTRIES INC.
$83
Biofrontera Inc.
$68
UCB, Inc.
$66
Blueprint Medicines Corporation
$28
Allergan Inc.
$25
SANOFI-AVENTIS U.S. LLC
$25
Verrica Pharmaceuticals Inc.
$24
Smith+Nephew, Inc.
$23
NOVARTIS PHARMACEUTICALS CORPORATION
$23
Kyowa Kirin, Inc.
$22
Celgene Corporation
$19
DUSA Pharmaceuticals, Inc.
$18
Medimetriks Pharmaceuticals, Inc.
$18
Mylan Pharmaceuticals Inc.
$15
Sebela Pharmaceuticals Inc.
$14
Top 3 companies account for 35.7% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ADBRY · ALTRENO · AMELUZ · AXXENT SURFACE CONTROLLER · Absorica LD · BLU-U · BOTOX · BOTOX COSMETIC · Bimzelx · CLODERM · COSENTYX · Cimzia · DUOBRII · DUPIXENT · ENSTILAR · EPIDUO FORTE · EUCRISA · Erivedge · GRAFIX PL · HYLATOPIC EMOLLIENT · ILUMYA · LEVULAN KERASTICK · LIBTAYO · NAFTIN · ODOMZO · ONEXTON · OPZELURA · ORACEA · Olux · Otezla · PICATO · Poteligeo · REMICADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · Seysara · Sitavig · Sotyktu · TALTZ · TREMFYA · TargaDox · Tremfya · WYNZORA · Winlevi · XEOMIN · Xeomin · Xolegel · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
382
Per 100K population
45.6
County median income
$107,327
Nearest hospital
LOS ROBLES HOSPITAL & MEDICAL CENTER
5.3 mi
5.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bastien is a clinical cardiology specialist, with above-average Medicare volume (top 11% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bastien experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Bastien performed 2,883 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bastien receive payments from pharmaceutical companies?
Yes. Dr. Bastien received a total of $8,534 from 40 companies across 219 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bastien's costs compare to other opticians in Westlake Village?
Dr. Bastien's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bastien) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Westlake Village
Browse opticians in Westlake Village ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
iCAD, Inc Payments to Doctors
See all physicians who received payments from iCAD, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology